Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Non-Therapeutic Biomolecules Global Market Report 2025
Download Free Sample Buy Now
Global Non-Therapeutic Biomolecules Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Non-Therapeutic Biomolecules Global Market Report 2025

By Trad Pharma( Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies), By End User( Research, Pharma, In vitro diagnostics(IVD)) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-Therapeutic Biomolecules Market Overview

• Non-Therapeutic Biomolecules market size has reached to $30.76 billion in 2024

• Expected to grow to $51.03 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%

• Growth Driver: The Surging Demand For Non-Therapeutic Biomolecules In Research And Laboratory Testing

• Market Trend: BASF And Caregen's Partnership Unleashes Innovative Peptovitae Series With Liposome-Encapsulation Technology

• Asia-Pacific was the largest region in 2024.

What Is Covered Under Non-Therapeutic Biomolecules Market?

Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning.

The main types of trad pharma of non-therapeutic biomolecules are enzymes, recombinant proteins, plasmids, peptides, oligonucleotides, and monoclonal antibodies. Enzymes are globular conjugated proteins that catalyze biological reactions by reducing the activation energy that increases the rate of the reaction. These are used by various end users such as research, pharma and In vitro diagnostics(IVD).

Non-Therapeutic Biomolecules Market Size and growth rate 2025 to 2029: Graph

What Is The Non-Therapeutic Biomolecules Market Size 2025 And Growth Rate?

The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $30.76 billion in 2024 to $33.92 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increased research and development (R&D) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, regulatory support.

What Is The Non-Therapeutic Biomolecules Market Growth Forecast?

The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $51.03 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, expanding application areas. Major trends in the forecast period include technological advancements, strategic collaborations, rising applications in agriculture, expanding role in industrial processes, customization and personalization.

The forecast of 10.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions may hinder U.S. biotech research by inflating prices of research-grade cytokines and growth factors manufactured in Finland and Singapore, resulting in delayed preclinical studies and higher drug discovery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Non-Therapeutic Biomolecules Market Segmented?

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

What Is Driving The Non-Therapeutic Biomolecules Market? The Surging Demand For Non-Therapeutic Biomolecules In Research And Laboratory Testing

The rapidly increasing number of research and laboratory testing is expected to propel the growth of the non-therapeutic biomolecules market going forward. Laboratory testing refers to the medical procedure that involves testing a sample of blood, urine, or other substance from the body to determine and monitoring of disease and draft a treatment plan, whereas research refers to the new knowledge is created, or current knowledge is creatively applied to produce new concepts, theories, and understandings. Non-therapeutic biomolecules in laboratory testing are used to measure the presence or concentration of a biomarker molecule that indicates disease, to enhance the sensitivity and specificity of the test. For instance, in July 2024, according to the National Health Service (NHS), a UK-based hospital and health care provider, diagnostic activity exceeded pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to the previous year. Therefore, the rapidly increasing number of research and laboratory testing is driving the growth of the non-therapeutic biomolecules industry.

What Is Driving The Non-Therapeutic Biomolecules Market? The Role Of Increased Healthcare Expenditure In Driving Growth Of The Non-Therapeutic Biomolecules Market

The increased healthcare expenditure is expected to propel the growth of the non-therapeutic biomolecules market going forward. Increased healthcare expenditure often leads to greater funding for medical research and development. Non-therapeutic biomolecules are often used in diagnostic tools and tests. Higher healthcare spending may indicate a greater emphasis on disease prevention, early detection, and personalized medicine. This increased focus on diagnostics can contribute to the growth of the non-therapeutic biomolecules market. For instance, in May 2024, the Office for National Statistics, a UK-based statistics authority, in 2023, healthcare expenditure in the UK was approximately £292 billion, reflecting a nominal increase of 5.6%. Additionally, long-term health and social care expenditure rose by 2.8% in real terms in 2022. Therefore, the increased healthcare expenditure is driving the growth of the non-therapeutic biomolecules industry during forecast period.

Who Are The Major Players In The Global Non-Therapeutic Biomolecules Market?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, EppendoRF AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

What Are The Key Trends Of The Global Non-Therapeutic Biomolecules Market? BASF And Caregen's Partnership Unleashes Innovative Peptovitae Series With Liposome-Encapsulation Technology

Product innovations are a key trend gaining popularity in the non-therapeutic biomolecules market. Major companies operating in the market are focused on research and development for product innovations to sustain their position in the market. For instance, in January 2022, BASF SE, a Germany-based multinational chemical company partnered with Caregen, a Korean-based company operating in biomimetic peptide research and development and introduced the Peptovitae series manufactured using liposome-encapsulation technology to expand its dermo-cosmetics portfolio to address a broad range of skin concerns with innovative and differentiated solutions. Liposomal encapsulation is a technique that uses fats to deliver essential vitamins or medications to specific body sections in tiny bubbles without affecting other body parts. The Peptovitae series addresses a wider range of skin concerns than are traditionally associated with the use of peptides such as signs of aging, enhancing the brightness of the skin, soothing skin prone to dryness and itching, and moisturizing skin.

What Are The Key Trends Of The Global Non-Therapeutic Biomolecules Market? Development Of New Cell Separation Technology To Increase Throughput And Optimize Processes

Major companies in the non-therapeutic biomolecules market are focusing on developing new cell separation technology to increase throughput and optimize processes, thus, to gain a competitive advantage in the market. This innovative research-only kit is created to provide scientists with a crucial solution to biological and lab workflow difficulties. For instance, in September 2022, Akadeum Life Sciences, a US-based biotechnology company, launched the Microbubble Leukopak Human T Cell Isolation Kit. The device combines the distinct features of microbubbles with a Buoyancy Activated Cell Sorting (BACSTM) Separation Tube, which has the potential to revolutionize large-volume cell separation procedures. The Microbubble Leukopak Human T Cell Isolation Kit employs microbubble technology which allows scientists to process up to twice the number of leukopaks in one-third the time of typical procedures, increasing productivity and optimizing operations.

Need data on a specific region in this market?
Request Regional Data

Non-Therapeutic Biomolecules Market Merger And Acquisition: Abbvie Acquires DJS Antibodies To Enhance Monoclonal Antibody Development

In October 2022, AbbVie Inc., a US-based healthcare company, acquired DJS Antibodies for $255 million. This acquisition aims to leverage DJS's innovative antibody technology and expertise in developing monoclonal antibodies, which can accelerate AbbVie's research and development efforts in targeted treatments. DJS Antibodies is a UK-based biopharmaceutical company that specializes in creating novel monoclonal antibodies for therapeutic applications.

Regional Outlook For The Global Non-Therapeutic Biomolecules Market

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecule market consists of sales of monosaccharides, disaccharides, polysaccharides, heteropolysaccharides, structural proteins, hormones, respiratory pigments, storage proteins, toxins, deoxyribonucleic acids (DNA), ribonucleic acids (RNA), fatty acids, phospholipids, steroids, eicosanoids, and glycolipids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Non-Therapeutic Biomolecules Industry?

The non-therapeutic biomolecules market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-therapeutic biomolecules industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Non-Therapeutic Biomolecules Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $33.92 billion
Revenue Forecast In 2034 $51.03 billion
Growth Rate CAGR of 10.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD) Subsegments: 1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides 6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Non-Therapeutic Biomolecules Market Characteristics

3. Non-Therapeutic Biomolecules Market Trends And Strategies

4. Non-Therapeutic Biomolecules Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Non-Therapeutic Biomolecules Growth Analysis And Strategic Analysis Framework

5.1. Global Non-Therapeutic Biomolecules PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Non-Therapeutic Biomolecules Market Growth Rate Analysis

5.4. Global Non-Therapeutic Biomolecules Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Non-Therapeutic Biomolecules Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Non-Therapeutic Biomolecules Total Addressable Market (TAM)

6. Non-Therapeutic Biomolecules Market Segmentation

6.1. Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Enzymes

Recombinant Proteins

Plasmids

Peptides

Oligonucleotides

Monoclonal Antibodies

6.2. Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research

Pharma

In vitro diagnostics(IVD)

6.3. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Industrial Enzymes

Diagnostic Enzymes

6.4. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antigens

Cytokines

Growth Factors

6.5. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Plasmids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research Plasmids

Expression Plasmids

6.6. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antimicrobial Peptides

Signaling Peptides

6.7. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antisense Oligonucleotides

RNAi Oligonucleotides

6.8. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research Antibodies

Diagnostic Antibodies

7. Non-Therapeutic Biomolecules Market Regional And Country Analysis

7.1. Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-Therapeutic Biomolecules Market

8.1. Asia-Pacific Non-Therapeutic Biomolecules Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-Therapeutic Biomolecules Market

9.1. China Non-Therapeutic Biomolecules Market Overview

9.2. China Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-Therapeutic Biomolecules Market

10.1. India Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-Therapeutic Biomolecules Market

11.1. Japan Non-Therapeutic Biomolecules Market Overview

11.2. Japan Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-Therapeutic Biomolecules Market

12.1. Australia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-Therapeutic Biomolecules Market

13.1. Indonesia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-Therapeutic Biomolecules Market

14.1. South Korea Non-Therapeutic Biomolecules Market Overview

14.2. South Korea Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-Therapeutic Biomolecules Market

15.1. Western Europe Non-Therapeutic Biomolecules Market Overview

15.2. Western Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-Therapeutic Biomolecules Market

16.1. UK Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-Therapeutic Biomolecules Market

17.1. Germany Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-Therapeutic Biomolecules Market

18.1. France Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-Therapeutic Biomolecules Market

19.1. Italy Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-Therapeutic Biomolecules Market

20.1. Spain Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-Therapeutic Biomolecules Market

21.1. Eastern Europe Non-Therapeutic Biomolecules Market Overview

21.2. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-Therapeutic Biomolecules Market

22.1. Russia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-Therapeutic Biomolecules Market

23.1. North America Non-Therapeutic Biomolecules Market Overview

23.2. North America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-Therapeutic Biomolecules Market

24.1. USA Non-Therapeutic Biomolecules Market Overview

24.2. USA Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-Therapeutic Biomolecules Market

25.1. Canada Non-Therapeutic Biomolecules Market Overview

25.2. Canada Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-Therapeutic Biomolecules Market

26.1. South America Non-Therapeutic Biomolecules Market Overview

26.2. South America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-Therapeutic Biomolecules Market

27.1. Brazil Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-Therapeutic Biomolecules Market

28.1. Middle East Non-Therapeutic Biomolecules Market Overview

28.2. Middle East Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-Therapeutic Biomolecules Market

29.1. Africa Non-Therapeutic Biomolecules Market Overview

29.2. Africa Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-Therapeutic Biomolecules Market Competitive Landscape And Company Profiles

30.1. Non-Therapeutic Biomolecules Market Competitive Landscape

30.2. Non-Therapeutic Biomolecules Market Company Profiles

30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Non-Therapeutic Biomolecules Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.

31.2. Agilent Technologies Inc.

31.3. Charles River Laboratories International Inc.

31.4. GE Healthcare Life Sciences

31.5. Fujifilm Diosynth Biotechnologies

31.6. Evonik Industries AG

31.7. Seikagaku Corporation

31.8. Takeda Pharmaceutical Company Limited

31.9. MilliporeSigma

31.10. Covance Inc.

31.11. Sartorius AG

31.12. Sanofi S.A.

31.13. CordenPharma International

31.14. Bayer AG

31.15. WuXi AppTec

32. Global Non-Therapeutic Biomolecules Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Therapeutic Biomolecules Market

34. Recent Developments In The Non-Therapeutic Biomolecules Market

35. Non-Therapeutic Biomolecules Market High Potential Countries, Segments and Strategies

35.1 Non-Therapeutic Biomolecules Market In 2029 - Countries Offering Most New Opportunities

35.2 Non-Therapeutic Biomolecules Market In 2029 - Segments Offering Most New Opportunities

35.3 Non-Therapeutic Biomolecules Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Plasmids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: UK, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: UK, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Germany, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Germany, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: France, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: France, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Italy, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Italy, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Spain, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Spain, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Russia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Russia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: North America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: North America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: USA, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: USA, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Canada, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Canada, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: South America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: South America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Africa, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Africa, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Amgen Inc. Financial Performance
  • Table 58: Genentech Inc. Financial Performance
  • Table 59: Merck KGaA Financial Performance
  • Table 60: Lonza Group AG Financial Performance
  • Table 61: Bio-Rad Laboratories Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Plasmids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: UK, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: UK, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Germany, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Germany, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: France, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: France, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Italy, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Italy, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Spain, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Spain, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Russia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Russia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: North America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: North America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: USA, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: USA, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Canada, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Canada, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: South America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: South America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Africa, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Africa, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Amgen Inc. Financial Performance
  • Figure 58: Genentech Inc. Financial Performance
  • Figure 59: Merck KGaA Financial Performance
  • Figure 60: Lonza Group AG Financial Performance
  • Figure 61: Bio-Rad Laboratories Inc. Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Read More About Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Read More About Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Read More About Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

Read More About Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Non-Therapeutic Biomolecules Global Market Report 2025 – By Trad Pharma( Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies), By End User( Research, Pharma, In vitro diagnostics(IV...

View Report

Peptide Therapeutics Global Market Report 2025 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, ...

View Report

Bioengineered Protein Drugs Global Market Report 2025 – By Drug Type (Recombinant Protein, Vaccine, Peptide Antibiotics, Therapeutic Enzymes, Other Drug Type), By Technology (Bioreactors, Fractionation, Genetically Modif...

View Report

Alternative Protein Global Market Report 2025 – By Source (Plant-Based, Insect-Based, Microbial-Based, Other Sources), By Form (Dry, Liquid), By Application (Food And Beverage, Cattle, Aquaculture, Animal Feed, Pet Food,...

View Report

Plasma Protein Therapeutics Global Market Report 2025 – By Product (Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products), By Route Of Administration (Intravenous, Subcutaneous), By Applica...

View Report

Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – By Type (Synthetic, Chemical, Biological), By Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular...

View Report

Difficult-to-Express Proteins Global Market Report 2025 – By Protein (Proteases, Kinases, Membrane Proteins, Other Proteins), By Expression Of Difficult Proteins (Disulfide-bonded Protein Expression, Membrane Protein Exp...

View Report

mRNA Therapeutics Global Market Report 2025 – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals And Clini...

View Report

Frequently Asked Questions

Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning. For further insights on this market, request a sample here

The market major growth driver - The Surging Demand For Non-Therapeutic Biomolecules In Research And Laboratory Testing. For further insights on this market, request a sample here

The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $30.76 billion in 2024 to $33.92 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increased research and development (R&D) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, regulatory support. The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to " $51.03 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, expanding application areas. Major trends in the forecast period include technological advancements, strategic collaborations, rising applications in agriculture, expanding role in industrial processes, customization and personalization. For further insights on this market, request a sample here

The non-therapeutic biomolecules market covered in this report is segmented –
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD) Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies For further insights on this market, request a sample here

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc. . For further insights on this market, request a sample here.

Major trends in this market include BASF And Caregen's Partnership Unleashes Innovative Peptovitae Series With Liposome-Encapsulation Technology. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Non-Therapeutic Biomolecules Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon